Navigation Links
Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study

th migraine. An innovative, two-stage, adaptive dose-ranging design formulated through computer simulation was used to facilitate optimal dose selection.

A total of 420 adult patients who experienced migraine attacks, as defined by the International Headache Society criteria, were randomized (330 took drug) to treat a moderate or severe migraine attack with MK-0974 given orally at doses of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg, or 600 mg, or rizatriptan 10 mg, or placebo. Patients enrolled were primarily female (89 percent) with an average age of 41 years. Most treated headaches were moderate in baseline severity and did not have aura.

The first stage of the study evaluated all doses of MK-0974 with rizatriptan and placebo. When a preset number of migraine attacks were treated, an interim efficacy analysis was conducted resulting in dropping the four lowest doses of MK-0974 based on a pre-specified algorithm. The second stage of the study continued with randomization of patients to MK-0974 300 mg, 400 mg or 600 mg or to rizatriptan 10 mg or placebo.

Overall treatment effect was analyzed by comparing the average response of the MK-0974 treatment groups (300 mg, 400 mg and 600 mg) to the response observed in the placebo group. The study was not powered to detect differences between the individual doses of MK-0974 or between MK-0974 doses and rizatriptan.

Study results

For the primary endpoint, the overall treatment effect of MK-0974 in relieving migraine pain (reduction from severe or moderate to mild or none) two hours after dosing was significant compared to placebo (p=0.015). The proportion of patients reporting pain relief at two hours for those treated with MK-0974 was 68.1 percent (300 mg; n=38), 48.2 percent (400 mg; n=45) and 67.5 percent (600 mg, n=40); and 69.5 percent for rizatriptan (n=34) compared to 46.3 percent for placebo (n=115).

A similar pattern was observed for secondary measures in which the overall
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
4. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
5. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:6/3/2015)... YORK , June 3, 2015 Trauma is ... as dislocation, fractures, or burns that are caused due to ... device is one of the most vital treatment methods adopted ... growth of the North America internal ... increasing adoption of supporting technologies. The North America ...
(Date:6/3/2015)... NEW YORK , June 3, 2015 The ... a CAGR of 8.3% from 2014 to 2019. In 2014, ... around 28.4% of the Asian pharmacy information systems market, followed ... a high potential for growth in future due to a ... venture capitalist investments, technological advancements, and increase number of healthcare ...
(Date:6/3/2015)... DIEGO , June 3, 2015  Diomics today ... clandestine service senior official, has joined the company,s board ... of the Intelligence Studies Project and Clinical Professor at ... the University of Texas at Austin. ... from having served 28 years as a member of ...
Breaking Medicine Technology:North America Internal Trauma Fixation Device Market, by Product Type, by End-User - Analysis & Forecasts to 2019 2Asia Pharmacy Information Systems Market By Type, By Component, By Deployment, By End-User - Analysis & Forecast To 2019 2Asia Pharmacy Information Systems Market By Type, By Component, By Deployment, By End-User - Analysis & Forecast To 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2
... June 3, 2011 CVS Caremark announced today that ... donations to support residents of Joplin, MO, including some ... their members, who were impacted by the recent tornado. ... and donated first aid and personal care supplies valued ...
... the 2011 SNM Annual Meeting in San Antonio, Siemens ... molecular imaging procedures and Siemens, efforts to expand molecular ... and new clinical applications. Through this benchmark-redefining growth of ... is "Expanding Your Return on Innovation." ...
Cached Medicine Technology:CVS Caremark and Area Colleagues Provide $40,000 of Support to Tornado Relief Efforts in Joplin, MO 2Siemens Expands Customer Return on Innovation at SNM 2011 2Siemens Expands Customer Return on Innovation at SNM 2011 3Siemens Expands Customer Return on Innovation at SNM 2011 4
(Date:6/3/2015)... EMBARGOED FOR RELEASE UNTIL 2 P.M. ET, WEDNESDAY, ... of Mother’s Home to Gas Wells , PITTSBURGH, June 3, ... of natural gas wells drilled with hydraulic fracturing were more ... living farther from such wells, according to a University ... southwestern Pennsylvania birth records. , The finding does not ...
(Date:6/3/2015)... The Canton Group, a leading web and software ... that Tim Dodge has joined the company as Chief ... Group as it implements an ambitious growth strategy ... is a tech industry veteran who has developed and ... Before joining The Canton Group, Tim was Vice President ...
(Date:6/3/2015)... On the heels of a report predicting ... ( click here to review news coverage about the ... has the talent to become a world-leading center of ... other biological data are collected and analyzed to help scientists ... the elements of a perfect storm for bioinformatics leadership,” said ...
(Date:6/3/2015)... June 03, 2015 Alberto Grignolo, PhD, ... DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program ... of excellence, and commitment to service on a global ... Connector Award that annually recognizes one DIA member for ... the mission of DIA to foster innovation to improve ...
(Date:6/3/2015)... Z-Medica®, LLC, a leading developer and ... been designated as National Safety Month by the National ... Department for its commitment to public safety. , ... First Aid Kits (IFAK) over 100 times in the ... or traffic accidents. Each kit is equipped with what’s ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2
... The 2009 Cumulative Supplement to ... legal developments in pharmaceutical patent law. Published by ... , Pharmaceutical Patent Law is supplemented annually ... implications of patent settlements; the experimental use privilege; and international ...
... after the nation,s largest financing source for fertility treatments shut down its ... today announced a new loan program for women ... Home National Bank, the program can finance up to half the cost ... an in vitro fertilization (IVF) procedure using fresh ...
... SAN ANTONIO, Oct. 14 Inc. magazine ranked ... its 28th annual Inc. 500, an exclusive ranking of the ... look at the most important segment of the economy--America,s independent-minded ... going to change the world, look at the Inc. 500," ...
... onerous, futile medical interventions are ordered for these end-stage ... -- Many people see end-stage dementia as affecting only ... disease,s effects are far-reaching and eventually fatal. , ... not a terminal condition can have negative ...
... Finding may help tailor treatments to keep patients from ... News) -- U.S. researchers have identified a common gene ... statin drugs. , Statins can reduce high cholesterol and ... 25 percent to 50 percent of people prescribed the ...
... , Using small molecules (purine analogs) ... in lung cancer, a common obstacle to successful, ... /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com (HTDS) - The ... brings attention to its Mindup Bioresearch cancer project ...
Cached Medicine News:Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 2Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 3Health News:New Fertility Financing Program for Donated Eggs Fills Void Left by Capital One 2Health News:Inc. Magazine Unveils 28th Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:Families Need to Know When Dementia Becomes Terminal 2Health News:Families Need to Know When Dementia Becomes Terminal 3Health News:Side Effects in Statin Users Linked to Gene Mutation 2Health News:Slavica Bio Chem MindUp Cancer Project (HTDS) Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 2Health News:Slavica Bio Chem MindUp Cancer Project (HTDS) Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 3Health News:Slavica Bio Chem MindUp Cancer Project (HTDS) Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: